NCT03267069 Evaluating Alcohol Use in Alcoholic Liver Disease
| NCT ID | NCT03267069 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Nicole T Shen |
| Condition | Alcoholic Liver Disease |
| Study Type | OBSERVATIONAL |
| Enrollment | 160 participants |
| Start Date | 2016-11-27 |
| Primary Completion | 2026-11-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 160 participants in total. It began in 2016-11-27 with a primary completion date of 2026-11-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This prospective, analytic observational study will investigate alcohol recidivism in patients with alcoholic liver disease. All adult subjects presenting with alcoholic liver disease are considered for inclusion. Subjects able to give consent are included.
Eligibility Criteria
Inclusion Criteria: * alcoholic liver disease able to consent Exclusion Criteria: * without alcoholic liver disease unable to consent
Contact & Investigator
Robert S Brown, MD, MPH
PRINCIPAL INVESTIGATOR
New York Presbyterian Hospital - Weill Cornell Medicine and Columbia University Medical Center
Frequently Asked Questions
Who can join the NCT03267069 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 80 Years, studying Alcoholic Liver Disease. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT03267069 currently recruiting?
Yes, NCT03267069 is actively recruiting participants. Contact the research team at nts9004@nyp.org for enrollment information.
Where is the NCT03267069 trial being conducted?
This trial is being conducted at New York, United States.
Who is sponsoring the NCT03267069 clinical trial?
NCT03267069 is sponsored by Nicole T Shen. The principal investigator is Robert S Brown, MD, MPH at New York Presbyterian Hospital - Weill Cornell Medicine and Columbia University Medical Center. The trial plans to enroll 160 participants.